Case Study: COVID Vax Exacerbates MS Symptoms

A team of multiple sclerosis researchers from Harvard Medical School and MS centers in Massachusetts and New York report an increase in MS symptoms in COVID-vaccinated individuals with MS.

Specifically, the team saw increased demyelination of the central nervous system (CNS) “consistent with active CNS demyelination of the optic nerve, brain and/or spinal cord. Symptoms included visual loss, dysmetria, gait instability, paresthesias, sphincter disturbance and limb weakness,” the researchers said in a case published in the Journal of Neurology.

Even though no one with MS was included in the original mRNA vaccine clinical trials, the Harvard team gave seven individuals the vaccine based on an observational study of 555 MS patients who took the shots in late December and early January 2021, who showed relatively few adverse reactions from it.

However, the Harvard team’s seven patients developed new neurological symptoms within a few weeks of either the first or second doses. The patients had “low” neurological disabilities before they were given the shots; three of them had no history at all of demyelinating disease.

While the Harvard team said they couldn’t definitively pin the vaccinations as the cause of the seven patients’ new symptoms since, theoretically, those symptoms could develop at any time in an MS patient, they did say “Our observations suggest that, in some individuals, COVID-19 vaccination may carry a short-term risk of CNS demyelination. This is in contrast with a recent study performed in Israel on 555 individuals with MS who received the Pfizer COVID-19 vaccine.”

 

SOURCES:

Journal of Neurology September 4, 2021

Multiple Sclerosis Journal April 2021

 

Can mRNA Gene Therapy Jabs Permanently Alter Your DNA?

 

Could a Simple Nasal Spray Be the Answer to COVID-19? yes

A nasal spray containing nitric oxide has been shown to reduce the viral load in COVID-19 cases by 95% within 24 hours, and 99% in 72 hours. The research, published in the Journal of Infection, is now in Phase II clinical trials.

Study authors said the treatment “was found to be effective and safe in reducing the viral load in patients with mild, symptomatic COVID-19 infection.”

Other studies with nasal sprays are also ongoing. For example, an in vitro study conducted jointly by researchers at Northwestern University and Utah State University found that a single blast of the over-the-counter sinus spray Xlear, made with grapefruit seed extract and xylitol, could reduce and nearly eliminate SARS-CoV-2, the virus that causes COVID-19.

In a press release Xlear study authors said the study breaks new ground because they found the spray could also help stave off H1N1 and emerging SARS-CoV-2 variants. On its website, xlear.com indicates the spray can be purchased at dozens of pharmacies and grocery stores.

 

SOURCES:

J Infect. 2021 Aug; 83(2): 237-279

ZeroHedge August 25, 2021

BioSpace January 26, 2021

BioSpace January 26, 2021

Xlear.com Website